In:
Microorganisms, MDPI AG, Vol. 4, No. 2 ( 2016-06-15), p. 20-
Kurzfassung:
Inflammatory Bowel Disease (IBD) is a multifactorial disorder that conceptually occurs as a result of altered immune responses to commensal and/or pathogenic gut microbes in individuals most susceptible to the disease. During Crohn’s Disease (CD) or Ulcerative Colitis (UC), two components of the human IBD, distinct stages define the disease onset, severity, progression and remission. Epigenetic, environmental (microbiome, metabolome) and nutritional factors are important in IBD pathogenesis. While the dysbiotic microbiota has been proposed to play a role in disease pathogenesis, the data on IBD and diet are still less convincing. Nonetheless, studies are ongoing to examine the effect of pre/probiotics and/or FODMAP reduced diets on both the gut microbiome and its metabolome in an effort to define the healthy diet in patients with IBD. Knowledge of a unique metabolomic fingerprint in IBD could be useful for diagnosis, treatment and detection of disease pathogenesis.
Materialart:
Online-Ressource
ISSN:
2076-2607
DOI:
10.3390/microorganisms4020020
Sprache:
Englisch
Verlag:
MDPI AG
Publikationsdatum:
2016
ZDB Id:
2720891-6
Permalink
